Comparison of survival in patients with pulmonary hypertension associated with fenfluramine to patients with primary pulmonary hypertension

Stuart Rich*, Alicia Shillington, Vallerie McLaughlin

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

To test whether the clinical presentation and prognosis of fenfluramine-induced pulmonary hypertension (PH) differs from primary PH (PPH), we compared the clinical profile and outcome of 10 patients with fenfluramine-induced PH with that of 70 patients with PPH referred to our center over the same time frame and treated identically. Patients with diet pill PH were similar to those with PPH with respect to hemodynamics. However, patients with fenfluramine-induced PH had poorer survival: 1-year survival 50% versus 88%, and 3-year survival 17% versus 60%.

Original languageEnglish (US)
Pages (from-to)1366-1368
Number of pages3
JournalAmerican Journal of Cardiology
Volume92
Issue number11
DOIs
StatePublished - Dec 1 2003

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Comparison of survival in patients with pulmonary hypertension associated with fenfluramine to patients with primary pulmonary hypertension'. Together they form a unique fingerprint.

Cite this